+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Cardiovascular risk factors prevalence among patients with dyslipidemia in Colombia



Cardiovascular risk factors prevalence among patients with dyslipidemia in Colombia



Revista Peruana de Medicina Experimental Y Salud Publica 30(2): 205-211



To determine the prevalence of cardiovascular risk factors and the ten years risk of cardio-cerebrovascular event in patients with dyslipidemia who were affiliated to the Colombian health system. A retrospective study was carried out in a random and stratified sample of 551 patients with dyslipidemia, from a population of 41,201 people with lipid-lowering therapy in ten Colombian cities between January 1, 2010 and June 30, 2011. Sociodemographic, anthropometric and biochemical variables were taken from medical records, as well as risk factors. To establish the 10-year cardiovascular risk was used Framingham algorithm. 311 patients were included, 56.4% of them were women, mean age 64.9 ± 10.8 years. The mean probability of developing a cardiovascular event at 10 years was 14%. Other cardiovascular risk factors found were hypertension (93.2%), male older than 55 years (35.8%), women older than 65 years (28.1%), diabetes mellitus (28.5%), family history of coronary heart disease (17.2%), personal history of heart disease or stroke (16.7%) and smoking (6.4%). The types of dyslipidemia by frequency were: mixed (46.6%), isolated hypercholesterolemia (29.4%) and hypertriglyceridaemia (20.3%). Patients were men and women older than 65 years, mainly suffering mixed dyslipidemia, and have a 14.0% probability of suffering a cardiovascular event in the next 10 years. It should promote healthy public policies to reduce the presence of hypertension and diabetes mellitus.

(PDF emailed within 1 workday: $29.90)

Accession: 051949389

Download citation: RISBibTeXText

PMID: 23949503


Related references

Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception. Clinica E Investigacion en Arteriosclerosis 26(6): 274-284, 2015

The Prevalence of Dyslipidemia and Other Cardiovascular Risk Factors in Youth with Diabetes. Current Pediatric Reviews: -, 2018

Prevalence of atherogenic dyslipidemia: association with risk factors and cardiovascular risk in Spanish working population. "ICARIA" study. Atherosclerosis 235(2): 562-569, 2015

Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study. Integrated Blood Pressure Control 1(): 5-13, 2008

Prevalence of risk factors for cardiovascular disease in tunja, colombia 27. 2012

Prevalence of dyslipidemia and elevated cardiovascular risk in patients with rheumatoid arthritis. Medicina 73(1): 26-30, 2013

Overview of cardiovascular risk factors in diabetic patients: focus on hypoglycemia, dyslipidemia, body weight and cardiovascular disease. Giornale Italiano di Cardiologia 14(12 Suppl): 4-8, 2016

Treatment of dyslipidemia to reduce cardiovascular risk in patients with multiple risk factors. Clinical Cornerstone 8 Suppl 6: S6-13, 2007

Data on prevalence of dyslipidemia and lipid values in Turkey: Systematic review and meta-analysis of epidemiological studies on cardiovascular risk factors. Turk Kardiyoloji Dernegi Arsivi 46(7): 556-574, 2018

Prevalence of dyslipidemia and borderline dyslipidemia and other risk factors of coronary heart disease in residents from Beijing communities. Zhonghua Xin Xue Guan Bing Za Zhi 38(2): 175-180, 2011

Exploring prognostic factors for achieving global cardiovascular risk reduction in high-risk patients with dyslipidemia and cardiometabolic syndrome on pharmacotherapy. 2007

Cardio-ankle vascular index value in dyslipidemia patients affected by cardiovascular risk factors. Clinical and Experimental Hypertension 40(4): 312-317, 2017

Management of dyslipidemia and other cardiovascular risk factors in HIV-infected patients: case-based review. Topics in HIV Medicine 14(4): 134-139, 2006

Honey and cardiovascular risk factors, in normal individuals and in patients with diabetes mellitus or dyslipidemia. Journal of Medicinal Food 16(12): 1063-1078, 2014

More about the effects of OMEGA-3 fatty acids on dyslipidemia and other cardiovascular risk factors in hemodialysis patients. Nephrology Dialysis Transplantation 10(6): 1007, 1995